Beyond Glucose: The Overlooked Role of Lipids in Gestational Diabetes

AIMS: To examine the role of maternal lipid metabolism before and during pregnancy in the development of gestational diabetes mellitus, and to evaluate its clinical implications for maternal and offspring outcomes. DATA SYNTHESIS: Shifts in lipid metabolism represent key physiologic adaptations of pregnancy, and, when dysregulated, may contribute to the pathogenesis of gestational diabetes. Lipid abnormalities typically precede conception, underscoring a continuum between pre-pregnancy metabolic health and pregnancy outcomes. Low HDL-C, elevated triglycerides, and small dense LDL-C particles have been repeatedly associated with increased gestational diabetes risk across several cohorts and meta-analyses, although the strength of these associations varies according to study design and population characteristics. During pregnancy, women with gestational diabetes display a reproducible lipid phenotype defined by higher triglycerides, lower HDL-C, and increased triglycerides/HDL-C ratios. These perturbations exacerbate insulin resistance, trigger inflammatory and oxidative stress pathways, and act as contributors to disease progression rather than secondary consequences of hyperglycemia. Clinically, maternal dyslipidemia has been associated with adverse outcomes including pre-eclampsia, gestational hypertension, severe hypertriglyceridemia-related pancreatitis, and neonatal complications such as macrosomia, large-for-gestational-age birth weight, and preterm delivery. Beyond pregnancy, lipid disturbances have been linked to unfavourable cardiometabolic trajectories in the offspring, suggesting transgenerational effects. CONCLUSIONS: Integrating mechanistic and clinical evidence, this review emphasizes the need for early lipid assessment, personalized nutritional counseling, and targeted interventions alongside glucose-centered care to improve maternal and offspring outcomes.